Clinical Trial Update: Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 study of ASM-024 in chronic obstructive pulmonary disease (GOLD 2-3), focusing on safety, tolerability, and clinical activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ASM-024

Snippet

Sponsor: Asmacure Ltée | Conditions: COPD | Phase 2 | Status: COMPLETED